3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
46
Lymphoma, Large B-Cell, Diffuse
26
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Leukemia, Myeloid, Acute
20
Lung Neoplasms
19
Burkitt Lymphoma
18
Recurrence
14
Lymphoma
14
Hodgkin Disease
14
Lymphoma, Non-Hodgkin
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
10
Neuroblastoma
10
Lymphoma, Mantle-Cell
10
Lymphoma, B-Cell
10
Leukemia
10
Carcinoma, Non-Small-Cell Lung
10
Medulloblastoma
8
Neoplasms, Germ Cell and Embryonal
7
Neoplasms
7
Lymphoma, Follicular
7
Multiple Myeloma
6
Lymphoma, T-Cell
6
Brain Neoplasms
6
Sarcoma, Ewing
5
Retinoblastoma
5
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Immunoblastic Lymphadenopathy
5
Ependymoma
5
Rhabdomyosarcoma
4
Rhabdoid Tumor
4
Interventions
Carboplatin
5
pembrolizumab
4
Pemetrexed
3
Paclitaxel
3
Cisplatin
3
selpercatinib
2
durvalumab
2
Radiosurgery
2
Gemcitabine
2
taletrectinib
1
repotrectinib
1
pralsetinib
1
ceralasertib
1
cemiplimab
1
Platinum Compounds
1
Nivolumab
1
Interleukin-15
1
Docetaxel
1
Blood Specimen Collection
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Bronchogenic
×
Etoposide
×
1 year
×
Clear all
No trials found.